T

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

TEVJF · CIK 0000818686

10 fiscal years · 0 SEC filings · every number carries its receipt

Revenue (FY)
$17.26B4.3%
FY2025
Net income (FY)
$1.41B186.0%
FY2025
Free cash flow (FY)
$1.15B53.3%
FY2025
Diluted EPS (FY)
$1.21183.4%
FY2025
The story, charted

The shape of the business

FY2016–FY2025 · hover any year for its receipt
Revenue & net incomeRevenueNet income
$0$20BFY2016 · Revenue $21.90B · Net income $329.0M · 0001193125-19-043564 · filed 2019-02-19FY16Revenue $21.90BNet income $329.0M0001193125-19-043564 · filed 2019-02-19FY2017 · Revenue $21.85B · Net income −$16.27B · 0001193125-20-044221 · filed 2020-02-21FY17Revenue $21.85BNet income −$16.27B0001193125-20-044221 · filed 2020-02-21FY2018 · Revenue $18.27B · Net income −$2.15B · 0001193125-21-036239 · filed 2021-02-10FY18Revenue $18.27BNet income −$2.15B0001193125-21-036239 · filed 2021-02-10FY2019 · Revenue $16.89B · Net income −$999.0M · 0001193125-22-032667 · filed 2022-02-09FY19Revenue $16.89BNet income −$999.0M0001193125-22-032667 · filed 2022-02-09FY2020 · Revenue $16.66B · Net income −$3.99B · 0001193125-23-031250 · filed 2023-02-10FY20Revenue $16.66BNet income −$3.99B0001193125-23-031250 · filed 2023-02-10FY2021 · Revenue $15.88B · Net income $417.0M · 0001193125-24-031005 · filed 2024-02-12FY21Revenue $15.88BNet income $417.0M0001193125-24-031005 · filed 2024-02-12FY2022 · Revenue $14.93B · Net income −$2.45B · 0001193125-25-020826 · filed 2025-02-05FY22Revenue $14.93BNet income −$2.45B0001193125-25-020826 · filed 2025-02-05FY2023 · Revenue $15.85B · Net income −$559.0M · 0001193125-26-034532 · filed 2026-02-03FY23Revenue $15.85BNet income −$559.0M0001193125-26-034532 · filed 2026-02-03FY2024 · Revenue $16.54B · Net income −$1.64B · 0001193125-26-034532 · filed 2026-02-03FY24Revenue $16.54BNet income −$1.64B0001193125-26-034532 · filed 2026-02-03FY2025 · Revenue $17.26B · Net income $1.41B · 0001193125-26-034532 · filed 2026-02-03FY25Revenue $17.26BNet income $1.41B0001193125-26-034532 · filed 2026-02-03FY25Revenue $17.26BNet income $1.41B0001193125-26-034532 · filed 2026-02-03FY17FY19FY21FY23FY25

net margin 1.5% → 8.2%

MarginsNet marginFCF margin
-50%0%FY2016 · Net margin 1.5% · FCF margin 13.6%FY16Net margin 1.5%FCF margin 13.6%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2017 · Net margin -74.4% · FCF margin 6.2%FY17Net margin -74.4%FCF margin 6.2%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2018 · Net margin -11.8% · FCF margin 9.8%FY18Net margin -11.8%FCF margin 9.8%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2019 · Net margin -5.9% · FCF margin 1.3%FY19Net margin -5.9%FCF margin 1.3%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2020 · Net margin -24.0% · FCF margin 3.8%FY20Net margin -24.0%FCF margin 3.8%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2021 · Net margin 2.6% · FCF margin 1.5%FY21Net margin 2.6%FCF margin 1.5%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2022 · Net margin -16.4% · FCF margin 7.0%FY22Net margin -16.4%FCF margin 7.0%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2023 · Net margin -3.5% · FCF margin 5.3%FY23Net margin -3.5%FCF margin 5.3%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2024 · Net margin -9.9% · FCF margin 4.5%FY24Net margin -9.9%FCF margin 4.5%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY2025 · Net margin 8.2% · FCF margin 6.7%FY25Net margin 8.2%FCF margin 6.7%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenueFY25Net margin 8.2%FCF margin 6.7%derived: net income ÷ revenue · derived: (ocf − capex) ÷ revenue’17’19’21’23’25

FY2025: net 8.2% · free cash flow 6.7% of revenue

Cash engineOperating cash flowFree cash flow
$0$2B$4BFY2016 · OCF $3.89B · FCF $2.99B · 0001193125-19-043564 · filed 2019-02-19FY16OCF $3.89BFCF $2.99B0001193125-19-043564 · filed 2019-02-19FY2017 · OCF $2.23B · FCF $1.35B · 0001193125-20-044221 · filed 2020-02-21FY17OCF $2.23BFCF $1.35B0001193125-20-044221 · filed 2020-02-21FY2018 · OCF $2.45B · FCF $1.79B · 0001193125-21-036239 · filed 2021-02-10FY18OCF $2.45BFCF $1.79B0001193125-21-036239 · filed 2021-02-10FY2019 · OCF $748.0M · FCF $223.0M · 0001193125-22-032667 · filed 2022-02-09FY19OCF $748.0MFCF $223.0M0001193125-22-032667 · filed 2022-02-09FY2020 · OCF $1.22B · FCF $638.0M · 0001193125-23-031250 · filed 2023-02-10FY20OCF $1.22BFCF $638.0M0001193125-23-031250 · filed 2023-02-10FY2021 · OCF $798.0M · FCF $236.0M · 0001193125-24-031005 · filed 2024-02-12FY21OCF $798.0MFCF $236.0M0001193125-24-031005 · filed 2024-02-12FY2022 · OCF $1.59B · FCF $1.04B · 0001193125-25-020826 · filed 2025-02-05FY22OCF $1.59BFCF $1.04B0001193125-25-020826 · filed 2025-02-05FY2023 · OCF $1.37B · FCF $842.0M · 0001193125-26-034532 · filed 2026-02-03FY23OCF $1.37BFCF $842.0M0001193125-26-034532 · filed 2026-02-03FY2024 · OCF $1.25B · FCF $749.0M · 0001193125-26-034532 · filed 2026-02-03FY24OCF $1.25BFCF $749.0M0001193125-26-034532 · filed 2026-02-03FY2025 · OCF $1.65B · FCF $1.15B · 0001193125-26-034532 · filed 2026-02-03FY25OCF $1.65BFCF $1.15B0001193125-26-034532 · filed 2026-02-03FY25OCF $1.65BFCF $1.15B0001193125-26-034532 · filed 2026-02-03’17’19’21’23’25

FY2025: $1.65B operating cash − $501.0M capex = $1.15B free cash flow

Returns on capitalReturn on equityReturn on assets
-100%-50%0%FY2017 · ROE -93.7% · ROA -23.0%FY17ROE -93.7%ROA -23.0%derived: net income ÷ equity · derived: net income ÷ assetsFY2018 · ROE -14.6% · ROA -3.5%FY18ROE -14.6%ROA -3.5%derived: net income ÷ equity · derived: net income ÷ assetsFY2019 · ROE -7.2% · ROA -1.7%FY19ROE -7.2%ROA -1.7%derived: net income ÷ equity · derived: net income ÷ assetsFY2020 · ROE -39.8% · ROA -7.9%FY20ROE -39.8%ROA -7.9%derived: net income ÷ equity · derived: net income ÷ assetsFY2021 · ROE 4.1% · ROA 0.9%FY21ROE 4.1%ROA 0.9%derived: net income ÷ equity · derived: net income ÷ assetsFY2022 · ROE -31.3% · ROA -5.6%FY22ROE -31.3%ROA -5.6%derived: net income ÷ equity · derived: net income ÷ assetsFY2023 · ROE -7.4% · ROA -1.3%FY23ROE -7.4%ROA -1.3%derived: net income ÷ equity · derived: net income ÷ assetsFY2024 · ROE -30.5% · ROA -4.2%FY24ROE -30.5%ROA -4.2%derived: net income ÷ equity · derived: net income ÷ assetsFY2025 · ROE 17.8% · ROA 3.5%FY25ROE 17.8%ROA 3.5%derived: net income ÷ equity · derived: net income ÷ assetsFY25ROE 17.8%ROA 3.5%derived: net income ÷ equity · derived: net income ÷ assets’17’19’21’23’25

return on equity -94% (FY2017) → 18% (FY2025) · on assets 3.5%

Balance sheetLiabilitiesEquity
$0$20B$40B$60BFY2017 · Liabilities $51.87B · Equity $17.36BFY17Liabilities $51.87BEquity $17.36B0001193125-19-043564 · filed 2019-02-19FY2018 · Liabilities $44.89B · Equity $14.71BFY18Liabilities $44.89BEquity $14.71B0001193125-20-044221 · filed 2020-02-21FY2019 · Liabilities $42.41B · Equity $13.97BFY19Liabilities $42.41BEquity $13.97B0001193125-21-036239 · filed 2021-02-10FY2020 · Liabilities $39.58B · Equity $10.03BFY20Liabilities $39.58BEquity $10.03B0001193125-22-032667 · filed 2022-02-09FY2021 · Liabilities $36.42B · Equity $10.28BFY21Liabilities $36.42BEquity $10.28B0001193125-23-031250 · filed 2023-02-10FY2022 · Liabilities $35.41B · Equity $7.80BFY22Liabilities $35.41BEquity $7.80B0001193125-24-031005 · filed 2024-02-12FY2023 · Liabilities $35.35B · Equity $7.51BFY23Liabilities $35.35BEquity $7.51B0001193125-25-020826 · filed 2025-02-05FY2024 · Liabilities $33.61B · Equity $5.37BFY24Liabilities $33.61BEquity $5.37B0001193125-26-034532 · filed 2026-02-03FY2025 · Liabilities $32.83B · Equity $7.91BFY25Liabilities $32.83BEquity $7.91B0001193125-26-034532 · filed 2026-02-03FY25Liabilities $32.83BEquity $7.91B0001193125-26-034532 · filed 2026-02-03’17’19’21’23’25

FY2025: $40.75B assets · $32.83B liabilities · $7.91B equity

The receipts